Elevance Health Inc. (ELV)
NYSE: ELV
· Real-Time Price · USD
350.77
10.53 (3.09%)
At close: Oct 03, 2025, 2:32 PM
3.09% (1D)
| Bid | 350.66 |
| Market Cap | 78.99B |
| Revenue (ttm) | 189.25B |
| Net Income (ttm) | 5.36B |
| EPS (ttm) | 24.25 |
| PE Ratio (ttm) | 14.46 |
| Forward PE | 10.57 |
| Analyst | Buy |
| Dividends | $8.39 |
| Ask | 351.25 |
| Volume | 1,767,453 |
| Avg. Volume (20D) | 2,457,728 |
| Open | 341.28 |
| Previous Close | 340.24 |
| Day's Range | 341.09 - 357.00 |
| 52-Week Range | 273.71 - 510.24 |
| Beta | 0.59 |
| Ex-Dividend Date | Sep 10, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for ELV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsElevance Health Inc. is scheduled to release its earnings on
Oct 21, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 hours ago
Shares of health insurers are trading higher amid ...
Unlock content with
Pro Subscription
4 weeks ago
-4.21%
Elevance Health shares are trading lower after the company reaffirmed its FY25 EPS guidance below estimates.
6 days ago · seekingalpha.com
Elevance Health: Undervalued Defensive Giant With Long-Term UpsideElevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line c...
4 weeks ago · https://thefly.com
Elevance Health price target raised to $373 from $327 at BarclaysBarclays raised the firm's price target on Elevance Health to $373 from $327 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare fa...
